Contineum Therapeutics, Inc. (CTNM) Ownership
CTNM ownership summary
as of October 18, 2026- Institutions
- 93.5% of shares outstanding
- Insiders
- 0.07% of shares outstanding
- Shares outstanding
- 33.0M
- Float
- 27.7M shares available to trade
- Short interest
- 9.36% 3.1M shares short
- Days to cover
- 5.03 short interest up 25.5% vs prior month
- Institutions 93.47%
- Insiders 0.07%
- Other investors 6.47%
CTNM top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Suvretta Capital Management, LLC | 7.55% | 2.8M | $20.1M | — | June 30, 2026 |
| 2 | HHG PLC | 7.27% | 2.7M | $19.4M | +285,857 (+11.7%) | March 31, 2026 |
| 3 | Jupiter Topco LLC | 7.27% | 2.7M | $19.4M | +2.7M (0.0%) | June 30, 2026 |
| 4 | BlackRock Inc | 5.49% | 2.1M | $14.6M | +1.4M (+208.5%) | June 30, 2026 |
| 5 | Johnson & Johnson | 5.26% | 2.0M | $14.0M | — | June 30, 2026 |
| 6 | Franklin Templeton Inc | 4.89% | 1.8M | $13.0M | — | June 30, 2026 |
| 7 | Balyasny Asset Management LLC | 4.05% | 1.5M | $10.8M | −162,842 (−9.7%) | June 30, 2026 |
| 8 | Vanguard Capital Management, LLC | 3.51% | 1.3M | $9.4M | +107,183 (+8.8%) | June 30, 2026 |
| 9 | Perceptive Advisors LLC | 3.34% | 1.3M | $8.9M | — | June 30, 2026 |
| 10 | FMR Inc | 2.76% | 1.0M | $7.4M | +225,259 (+27.6%) | June 30, 2026 |
| 11 | Millennium Management LLC | 2.48% | 932K | $6.6M | −603,740 (−39.3%) | June 30, 2026 |
| 12 | Great Point Partners LLC | 2.45% | 921K | $6.5M | +121,283 (+15.2%) | June 30, 2026 |
| 13 | Longaeva Partners L.P. | 2.16% | 813K | $5.8M | +80,669 (+11.0%) | June 30, 2026 |
| 14 | Ikarian Capital, LLC | 2.15% | 808K | $5.7M | — | June 30, 2026 |
| 15 | Sectoral Asset Management Inc | 1.93% | 728K | $5.2M | — | June 30, 2026 |
| 16 | Geode Capital Management, LLC | 1.84% | 693K | $4.9M | +411,150 (+145.8%) | June 30, 2026 |
| 17 | Hillhouse Capital Advisors, Ltd. | 1.78% | 669K | $4.7M | — | June 30, 2026 |
| 18 | Red Tree Management, LLC | 1.70% | 638K | $4.5M | — | June 30, 2026 |
| 19 | Versant Venture Management LLC | 1.44% | 543K | $3.8M | — | June 30, 2026 |
| 20 | The Goldman Sachs Group Inc | 1.32% | 497K | $3.5M | +190,147 (+61.9%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 9 holders added 5.6M shares and 2 cut 767K.
CTNM top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Franklin Biotechnology Discv A(acc)USD | 2.93% | 1.1M | $7.8M | −59,706 (−5.1%) | August 31, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 2.61% | 982K | $7.0M | — | August 31, 2026 |
| 3 | iShares Russell 2000 ETF | 1.91% | 717K | $5.1M | −8,256 (−1.1%) | September 30, 2026 |
| 4 | Franklin Biotechnology Discovery A | 1.60% | 601K | $4.3M | −23,987 (−3.8%) | August 31, 2026 |
| 5 | Fidelity Select Health Care | 1.20% | 450K | $3.2M | — | August 31, 2026 |
| 6 | Fidelity Small Cap Index | 0.78% | 295K | $2.1M | +3,408 (+1.2%) | July 31, 2026 |
| 7 | Fidelity Advisor Health Care I | 0.74% | 280K | $2.0M | — | August 31, 2026 |
| 8 | iShares Russell 2000 Value ETF | 0.68% | 256K | $1.8M | +388 (+0.2%) | September 30, 2026 |
| 9 | State Street® SPDR® S&P® PhrmctlsETF | 0.67% | 253K | $1.8M | −3,144 (−1.2%) | September 30, 2026 |
| 10 | iShares Biotechnology ETF | 0.62% | 233K | $1.7M | −1,768 (−0.8%) | September 30, 2026 |
| 11 | Fidelity Advisor Biotechnology I | 0.60% | 225K | $1.6M | — | August 31, 2026 |
| 12 | Fidelity Small Cap Stock | 0.47% | 177K | $1.3M | +176,600 (0.0%) | July 31, 2026 |
| 13 | Schwab US Small-Cap ETF™ | 0.42% | 160K | $1.1M | +108 (+0.1%) | September 30, 2026 |
| 14 | Vanguard Russell 2000 ETF | 0.41% | 155K | $1.1M | +3,708 (+2.5%) | August 31, 2026 |
| 15 | Fidelity Extended Market Index | 0.35% | 130K | $920,853 | +608 (+0.5%) | August 31, 2026 |
| 16 | iShares Micro-Cap ETF | 0.23% | 88K | $625,737 | −610 (−0.7%) | September 30, 2026 |
| 17 | Fidelity VIP Health Care Initial | 0.21% | 80K | $566,400 | — | August 31, 2026 |
| 18 | Schwab Small Cap Index | 0.17% | 65K | $461,375 | — | August 31, 2026 |
| 19 | Dimensional US Small Cap ETF | 0.16% | 60K | $421,508 | — | September 30, 2026 |
| 20 | Avantis US Small Cap Equity ETF | 0.14% | 53K | $374,773 | +90 (+0.2%) | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
CTNM shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns CTNM
Institutional investors own 93.5% of Contineum Therapeutics's shares and insiders 0.07%. The largest holder is Suvretta Capital Management, LLC with 7.55% of the shares (2.8M), as of June 30, 2026. Among the top 20 institutions, 9 added shares and 2 reduced their stake in the latest filings. Short interest is 9.36% of the float, or 5.03 days of average trading volume. The share count rose 22.8% since 2022.
Related: CTNM analyst forecast, CTNM key metrics. See the CTNM stock overview for the latest quote and news.
CTNM ownership FAQ
Who owns the most Contineum Therapeutics stock?
The largest shareholders of Contineum Therapeutics are Suvretta Capital Management, LLC (7.55%), HHG PLC (7.27%), Jupiter Topco LLC (7.27%), BlackRock Inc (5.49%), Johnson & Johnson (5.26%).
What percentage of Contineum Therapeutics is owned by institutions?
Institutions hold 93.5% of Contineum Therapeutics's shares outstanding; insiders hold 0.07%.
Which funds own Contineum Therapeutics?
The largest fund holders of Contineum Therapeutics are Franklin Biotechnology Discv A(acc)USD (2.93%), Vanguard MStar Total Stk Mkt Idx Invest (2.61%), iShares Russell 2000 ETF (1.91%), Franklin Biotechnology Discovery A (1.60%), Fidelity Select Health Care (1.20%).
What is Contineum Therapeutics's short interest?
3.1M shares of Contineum Therapeutics were sold short, 9.36% of the float; at the average daily volume it would take 5.03 days to cover.
How many shares of Contineum Therapeutics are outstanding?
Contineum Therapeutics has 33.0M shares outstanding, of which 27.7M are in the public float.